tiprankstipranks
Advertisement
Advertisement
CR Double-Crane Posts Softer Q1 Earnings but Stronger Cash Position for 2026
PremiumCompany AnnouncementsCR Double-Crane Posts Softer Q1 Earnings but Stronger Cash Position for 2026
16d ago
CR Jiangzhong Q1 2026 Profit Rises on Strong Cash Flow Despite Revenue Dip
Premium
Company Announcements
CR Jiangzhong Q1 2026 Profit Rises on Strong Cash Flow Despite Revenue Dip
16d ago
China Resources Pharma Flags Higher Q1 Profit at Tasly but Warns on Cash Outflow and Limited Scope
Premium
Company Announcements
China Resources Pharma Flags Higher Q1 Profit at Tasly but Warns on Cash Outflow and Limited Scope
16d ago
China Resources Pharmaceutical Delivers Higher Revenue and Profit in 2025
PremiumCompany AnnouncementsChina Resources Pharmaceutical Delivers Higher Revenue and Profit in 2025
2M ago
China Resources Pharmaceutical Declares Final 2025 Dividend With Currency Option
Premium
Company Announcements
China Resources Pharmaceutical Declares Final 2025 Dividend With Currency Option
2M ago
CR Sanjiu Posts Strong Asset and Revenue Growth, Boosts Dividend for 2025
Premium
Company Announcements
CR Sanjiu Posts Strong Asset and Revenue Growth, Boosts Dividend for 2025
2M ago
CR Jiangzhong Lifts Profit and Dividend Despite Revenue Dip in 2025
PremiumCompany AnnouncementsCR Jiangzhong Lifts Profit and Dividend Despite Revenue Dip in 2025
2M ago
China Resources Pharmaceutical Plans Further Stake Sale in Tianmai Biotechnology
Premium
Company Announcements
China Resources Pharmaceutical Plans Further Stake Sale in Tianmai Biotechnology
2M ago
China Resources Pharmaceutical Sets March Board Meeting on 2025 Results, Dividend Plan
Premium
Company Announcements
China Resources Pharmaceutical Sets March Board Meeting on 2025 Results, Dividend Plan
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100